Leukemia Treatment
Leukemia is a cancer of the blood and bone marrow. It develops when abnormal white blood cells grow and multiply in an uncontrolled way, interfering with the body’s ability to produce healthy blood cells and fight infection.
At CMN Hospital, leukemia cases are reviewed individually based on diagnosis, blood counts, bone marrow findings, pathology, genetic or molecular testing, prior treatments, current health status, and overall medical condition.
Types of Leukemia
Leukemia is generally classified by how quickly the disease progresses and by the type of blood cell involved. Acute leukemias may progress quickly and require urgent medical attention, while chronic leukemias may develop more slowly over time.
Acute Myeloid Leukemia
AML affects the myeloid blood cell line and can progress rapidly.
Acute Lymphoblastic Leukemia
ALL affects immature lymphoid cells and may occur in both adults and children.
Chronic Lymphocytic Leukemia
CLL is a slower-growing leukemia involving lymphocytes and is more common in adults.
Chronic Myeloid Leukemia
CML involves the myeloid blood cell line and is often associated with specific genetic changes.
Other leukemia-related diagnoses may include:
- Hairy Cell Leukemia
- Myelodysplastic Syndromes
- Myeloproliferative Neoplasms
- Mixed Phenotype Acute Leukemia
- Recurrent or Relapsed Leukemia
Signs and Symptoms
Leukemia symptoms may develop gradually or appear suddenly, depending on the type and pace of the disease.
- Persistent fatigue or weakness
- Frequent infections
- Easy bruising or bleeding
- Unexplained fevers or night sweats
- Shortness of breath
- Pale skin
- Bone or joint pain
- Swollen lymph nodes
- Unexplained weight loss
- Enlarged spleen or abdominal fullness
How Leukemia Is Diagnosed
Diagnosing leukemia usually requires laboratory and bone marrow evaluation. Testing helps determine the leukemia type, disease burden, genetic features, and possible treatment options.
- Complete blood count with differential
- Peripheral blood smear
- Bone marrow biopsy and aspiration
- Flow cytometry
- Cytogenetic testing
- Molecular or genetic testing
- Imaging studies when clinically indicated
- Review of prior treatment records and response history
Conventional Treatment Options
Treatment for leukemia depends on the specific type, stage or phase, genetic findings, age, prior therapies, response to treatment, and overall health.
- Chemotherapy
- Targeted therapy
- Immunotherapy
- Monoclonal antibody therapy
- Tyrosine kinase inhibitors for selected leukemias
- Stem cell or bone marrow transplant in selected cases
- Supportive care, including transfusions and infection management
- Clinical trials when appropriate
Advanced, Relapsed, or Persistent Leukemia
Some patients who contact CMN Hospital have already received chemotherapy, targeted therapy, immunotherapy, transplant consultation, or other treatments before seeking additional options. Others may have relapsed, persistent, or treatment-resistant leukemia.
Because leukemia can behave very differently from one patient to another, treatment recommendations cannot be based on diagnosis alone. A careful physician review is needed before discussing whether CMN Hospital’s 28-day inpatient Advanced Cancer Treatment program may be appropriate.
Individualized Physician Review
At CMN Hospital, every patient is evaluated individually. Dr. Edgar Payán, General Hospital Director and Medical Director of CMN Hospital, personally reviews each patient’s blood work, pathology reports, bone marrow findings, imaging studies, genetic or molecular testing, previous treatments, current health status, and other relevant medical records.
Following this comprehensive review, Dr. Payán meets personally with each patient during a consultation to discuss the findings, answer questions, determine whether CMN Hospital’s 28-day inpatient Advanced Cancer Treatment program may be appropriate, and explain the treatment options available based on the patient’s individual medical evaluation.
If a patient proceeds with treatment, Dr. Payán oversees their care throughout their inpatient stay and continues to personally monitor their progress through scheduled monthly Zoom follow-up appointments after discharge.